MINNEAPOLIS, Jan. 7, 2013 /PRNewswire/ -- Coloplast U.S. today announced that the company has signed a three year agreement with Novation, the largest healthcare supply chain expertise and contracting company for the more than 65,000 acute and non-acute members of four U.S. national healthcare alliances.
The agreement will offer Coloplast's technologies to the more than 2,500 hospitals served by Novation, nearly doubling the company's current U.S. reach. This will offer Coloplast's most innovative technologies in Ostomy Care to 80 percent of the U.S. market. It includes the SenSura® product line and SenSura® Mio, an advanced colostomy appliance that uses BodyFit technology to adjust to individual body types and takes security to a new level.
"Our mission is to make life easier for people with very personal and private medical conditions. We know that our products make a real and important difference in people's lives. Starting today, more Americans will have access to the most innovative technologies in Ostomy Care," said Claus Bjerre, President, Chronic Care, Coloplast Corp.
"We are very pleased with our agreement with Novation, which we are confident will benefit the members they serve and the people who rely on our products every day," Bjerre said. "Furthermore, the agreement will accelerate our sales process and increase our visibility in the market, creating a stronger competitive platform for growing our U.S. business."
The agreement is for three years, starting 1 January 2013 and ending on 31 December 2015.
Novation is the leading healthcare supply chain expertise and contracting company for the more than 65,000 members of national healthcare alliances VHA Inc. and UHC, two national health care alliances, Children's Hospital Association, an alliance of the nation's leading pediatric facilities, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services.
Novation serves healthcare markets such as acute hospitals and systems, academic medical centers, ambulatory care, physician clinics, home health and long-term care facilities. VHA, UHC, and Provista members used Novation contracts to purchase more than $40 billion in 2011.
To learn more about Novation, visit www.novationco.com
A Danish based medical device company with its United States headquarters in Minneapolis, Coloplast develops medical devices and services designed to make life easier for people with very personal and private medical conditions. We start by listening to our users to better understand their needs, and then respond by bringing the best ideas to market in the form of medical devices and service solutions.
Coloplast's businesses include ostomy care, urology care, continence care, and wound and skin care. With the development of a strong portfolio of new products and investments in a professional sales force, Coloplast now employs around 8000 people worldwide. In 2012, Coloplast received global recognition for having the best corporate reputation among patients (PatientView), and for being the Most Ethical (Ethisphere Institute) and Most Sustainable (StoreBrand Bank) company.
To learn more about Coloplast, visit www.us.coloplast.com